Charles Cooney

[Charles Cooney @CLCMIT]

Global spending on drugs to exceed $1 tn; this speaks for itself... http://t.co/n29kCaUhjt http://t.co/ExWKfpQeHV via @FT

[Charles Cooney @CLCMIT]

Discussed in class, drug compounding rules address weakness in supply chain http://t.co/iSOvSTly0Z via @BostonGlobe

[Charles Cooney @CLCMIT]

3D printing, what are the broader dimensions of this innovation in health care? http://t.co/l53TR4A8eL via @FT

[Charles Cooney @CLCMIT]

Can you place a New Class of Cholesterol Drugs into broader life cycle perspective? http://t.co/g3VS10nsH4

[Charles Cooney @CLCMIT]

Panel recommends wider use of cholesterol drugs http://t.co/gfubL5SSVa via @BostonGlobe

[Charles Cooney @CLCMIT]

Novo Nordisk, a company, market and drug perspective - http://t.co/n29kCaUhjt http://t.co/OZLeqsWYqY via @FT

[Charles Cooney @CLCMIT]

there is a clear restructuring trend as noted in the article http://t.co/oJmupA9NMr via @FT

[Charles Cooney @CLCMIT]

Biotech stock boom a balance of opportunity & risks. http://t.co/YC1hxT8Foo via @FT

[Charles Cooney @CLCMIT]

Vertex will cut 370 jobs - the uncertainty of mkt forecast. http://t.co/1iy3bSvN8i via @BostonGlobe

[Charles Cooney @CLCMIT]

McKesson takeover of Celesio - implications to supply chain, distribution, data, ... - http://t.co/n29kCaUhjt http://t.co/5AVPoYNPB2 via @FT

[Charles Cooney @CLCMIT]

F.D.A. Shift on Painkillers - Look at implications across value chain and stakeholders http://t.co/52T4TZqcb1

[Charles Cooney @CLCMIT]

Samsung will make some Roche biologics - consider as Manufacturing strategy http://t.co/A5nQrJDRAv

[Charles Cooney @CLCMIT]

Chinese vaccine company international approval has broad implications- http://t.co/n29kCaUhjt http://t.co/cxDOtqV2rY via @FT

[Charles Cooney @CLCMIT]

Try to put this in perspective - Why the Bad Rap on Generic Drugs? http://t.co/2YaJYDQzGi

[Charles Cooney @CLCMIT]

Lilly, Pfizer to work with Joslin on kidney failure treatments http://t.co/wntQLHKUHi via @BostonGlobe

[Charles Cooney @CLCMIT]

Struggling Merck slashing 8,500 jobs in major R&D, commercial reorganization http://t.co/iPnPQmaNGU

[Charles Cooney @CLCMIT]

Roche co-op'n with Novartis - http://t.co/n29kCaUhjt http://t.co/vuc2dr68L1 via @FT . context of partnerships in drug development

[Charles Cooney @CLCMIT]

Google launches healthcare company - http://t.co/n29kCaUhjt http://t.co/QDtG3KrRlF via @FT. what do you think are the implications of this?

[Charles Cooney @CLCMIT]

Concern Over Drug Costs http://t.co/Ppmxd6PEwv

[Charles Cooney @CLCMIT]

Merck R&D chief spotlights streamlining, biologics and the new risk strategy http://t.co/xD07LEE6f0